Caris expands its extensive network of leading
cancer institutions committed to improving patient outcomes through
innovations in precision medicine by welcoming the University of
Hawai'i Cancer Center
IRVING,
Texas, Aug. 19, 2024 /PRNewswire/ -- Caris Life
Sciences®(Caris), a leading next-generation AI TechBio
company and precision medicine pioneer, announced today that the
University of Hawai'i Cancer Center (UH Cancer Center) has joined
the Caris Precision Oncology Alliance™ (Caris POA).
The Caris POA expands its extensive network
of leading cancer institutions committed to improving patient
outcomes
The Caris POA is a growing network of leading cancer centers and
research consortia across the globe that collaborate to advance
precision oncology and biomarker-driven research, with its members
working together to establish and optimize standards of care for
molecular testing through innovative research to improve clinical
outcomes for cancer patients. POA members are uniquely positioned
to leverage Caris' highly sophisticated AI bioinformatics and
machine learning capabilities across Caris' massive multi-modal
database to enable innovative research to improve clinical outcomes
for cancer patients.
The UH Cancer Center, an organized research unit within the
University of Hawaiʻi at Mānoa, is one of only 72 research
organizations in the U.S. designated by the National Cancer
Institute, and the only one in Hawaiʻi and the Pacific. With a
history of over five decades, the UH Cancer Center is housed in a
world-class facility built in 2013 in Honolulu, with 300 research faculty, staff and
students who focus on key cancers that significantly impact
communities in Hawaiʻi and the Pacific. As the central cancer
research, education and training hub, the UH Cancer Center
contributes to a global body of knowledge to aid in the development
of innovative cancer prevention and control strategies and novel
life-saving therapies and interventions for all types of
cancers.
"We're pleased to welcome the University of Hawai'i Cancer
Center into the growing Caris Precision Oncology Alliance," said
George W. Sledge, Jr., MD, EVP and
Chief Medical Officer of Caris. "UH Cancer Center's focus on
reducing the burden of cancer through research, education, patient
care and community outreach makes them a valuable alliance member.
We look forward to collaborating with their team of investigators
on our shared mission of improving the outcomes of all patients
affected by cancer."
"We are excited to collaborate academically and mutually learn
clinically from our colleagues on the continent," said Naoto T. Ueno, MD, PhD, FACP, Director of the
University of Hawaiʻi Cancer Center. "This opportunity will foster
more clarity in our understanding of cancer genomics in our
racially and ethnically diverse community so that we can provide
better treatments."
The Caris POA includes 95 cancer centers, academic institutions,
research consortia and healthcare systems. These institutions have
early access to the extensive database and artificial intelligence
platform within Caris to establish evidence-based standards for
cancer profiling and molecular testing in oncology. By leveraging
the comprehensive genomic, transcriptomic and proteomic profiling
available through Caris molecular profiling, Caris seeks to provide
this network with the ability to prioritize therapeutic options and
determine which clinical trial opportunities may benefit their
patients. POA members are also able to integrate with a growing
portfolio of biomarker-directed trials sponsored by biopharma.
Additionally, POA member institutions have access to one of the
largest and most comprehensive multi-modal databases in the
industry, which includes matched molecular and clinical outcomes
data from hundreds of thousands of cancer patients, covering tens
of billions of datapoints per patient.
About Caris Life Sciences
Caris Life
Sciences® (Caris) is a leading next-generation AI
TechBio company and precision medicine pioneer that is actively
developing and delivering innovative solutions to revolutionize
healthcare and improve the human condition. Through comprehensive
molecular profiling (Whole Exome and Whole Transcriptome
Sequencing) and the application of advanced AI and machine learning
algorithms, Caris has created the large-scale, multi-modal database
and computing capability needed to analyze and unravel the
molecular complexity of disease. This convergence of sequencing
power, big data and AI technologies provides an unmatched platform
to deliver the next generation of precision medicine tools for
early detection, diagnosis, monitoring, therapy selection and drug
development.
Caris was founded with a vision to realize the potential of
precision medicine in order to improve the human condition, and we
value our employees as much as we do our patients of every creed,
color, sex, sexual orientation and religion. Headquartered in
Irving, Texas, Caris has offices
in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor
partners provide services in the U.S., Europe, Asia
and other international markets. To learn more, please visit
CarisLifeSciences.com.
About the University of Hawaiʻi Cancer Center
The
University of Hawaiʻi Cancer Center is dedicated to conquering
cancer, inspiring hope, and saving lives in Hawai'i and the
Pacific. The center strives to do this through research, education,
patient care and community outreach, with an emphasis on the
diverse and unique ethnic, cultural, and environmental
characteristics of Hawaiʻi and the Pacific. The UH Cancer Center
adds more than $57 million to the
Oʻahu economy through scientific research, clinical trials and
numerous other activities. It is one of only 72 cancer-research
institutions designated by the National Cancer Institute, a mark of
excellence, and the only NCI-designated cancer center in Hawai'i
and the Pacific. Learn more at uhcancercenter.org. Connect with us
on Facebook/Instagram/Twitter @UHCancerCenter.
Caris Life Sciences Media Contact:
Lisa Burgner
Corpcomm@CarisLS.com
214.294.5606
The University of Hawaiʻi Cancer Center Media
Contact:
Esme M. Infante,
Director of Communications
einfante@cc.hawaii.edu
808.564.5911
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-caris-precision-oncology-alliance-welcomes-the-university-of-hawaii-cancer-center-302224674.html
SOURCE Caris Life Sciences